Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial

Research output: Contribution to journalArticlepeer-review

65 Downloads (Pure)
Original languageEnglish
JournalBMC Cancer
Publication statusAccepted/In press - 22 Oct 2022

Cite this